Answers are grounded in this paper and cite their sources.
Delphi panel confirms HBIG and NUCs as standard for HBV prevention post-liver transplantation, suggesting variability in practice.
This modified Delphi panel confirmed that life-long combination of HBIG and NUCs remains the gold standard for the HBV prophylaxis after LT. Significant variability persists in clinical practice. Prophylactic strategies, especially in low-risk patients, are largely determined on a case-by-case basis, guided by patient characteristics rather than standardized protocols.
No takes yet. Share an insight, caveat, or question.
Battistella et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: